Outcome of Neonatal Sacro-coccygeal Teratoma at a tertiary care centre

Ramdhani Yadav; Sandip Kumar Rahul; Vinit Kumar Thakur

Volume : VII, Issue : IV, April - 2018

Outcome of Neonatal Sacro-coccygeal Teratoma at a tertiary care centre

Ramdhani Yadav, Sandip Kumar Rahul, Vinit Kumar Thakur

Abstract :

Aim: To analyze the clinical characteristics and outcome of neonatal Sacrococcygealteratoma(SCT) treated at our centre.

Materials and Methods: A retrospective study was conducted on 17neonates, who were treated for SCT from January, 2013 to December, 2017. Hospital records of these patients including the clinical features, surgical details and follow–up details were retrieved and data thus collected were analyzed. Patients who did not come for follow–up were contacted telephonically and called for periodic checkups.

Results: Out of 17 patients, 12 girls and 5 boys presented with a mean age of 11 days (range 1– 28 days).One of the patients presented at 28 days after birth in profound sepsis with a fungating ruptured sacrococcygeal mass which led to her demise on the day of her presentation. Remaining 16 patients were operated in the neonatal period. Only 5 of these patients had antenatal ultrasound detection. Two patients presented with tumor rupture. 13 patients had a large tumor size with diameter exceeding 10cm. One patient with a small tumor was misdiagnosed as meningomyelocoele. While 15 patients were Altman Type I, 2 patients had Altman Type II tumor. All the 16 surviving patients underwent complete surgical excision with coccygectomy. Histopathological examination showed mature cystic teratoma in 14 patients and immature elements in 2 patients. Following surgery, wound infection was seen in 3 patients and one patient had neurogenic bladder.No mortality was seen in the 16 patients who were operated. Mean follow–up was 30 months (range – 6months to 36months) in twelve patients. 4 patients were lost to follow–up after surgery.

Conclusions: Complete surgical excision of Neonatal Sacro–coccygeal teraroma is usually possible, considering the early presentation of Altman Type I and II. Histopathology mostly shows mature elements showing good prognosis. Considering the long term risks of recurrence, periodic follow–up with clinical and tumor marker assessment is a must to detect recurrences early and intervene promptly.